BioPharma Cell & Gene Therapy Nexus Conference

May 4th & 5th 2027

Sheraton Brussels Airport Hotel, Belgium

0
Days
0
Hours
0
Mins
0
Secs
Be A Participant

From Cells to Cures: Driving the Future of Medicine



The BioPharma Cell & Gene Therapy Nexus Conference 2027 is a distinguished two-day global gathering dedicated to advancing the science, development, and application of cell and gene therapies. Designed to unite senior executives from pharmaceutical and biotechnology companies with select solution providers, the Nexus offers a highly focused environment that encourages strategic dialogue, peer-to-peer learning, and meaningful professional exchange, propelling the future of advanced therapies.

This conference provides an essential stage for unveiling groundbreaking research, showcasing transformative innovations, and sharing practical advancements across the field. Participation offers the chance to connect with thought leaders, gain actionable insights, and contribute to shaping the next chapter of cell and gene therapy.

Far more than a traditional meeting, the Nexus serves as a catalyst for collaboration. It strengthens critical partnerships, accelerates the translation of pioneering science into clinical practice, and brings together diverse stakeholders to drive innovation, disseminate expertise, and ultimately improve patient outcomes worldwide.

Agenda at a Glance

Cell Therapy

Cell Therapy

Unlock next-generation approaches in autologous and allogeneic cell therapy manufacturing, combining automation, decentralized production, and efficient scale-up strategies to drive cost efficiency and improve product consistency.

Gene Therapy

Gene Therapy

Enhance gene therapy manufacturing efficiency through advanced upstream and downstream solutions. Enable faster approvals with integrated analytics, optimized process control, and comprehensive characterization while ensuring product quality and consistency.

Breakthrough Speaking Sessions

Breakthrough Speaking Sessions

This is not a conventional tradeshow, it is a highly curated gathering designed to inspire meaningful exchange. Featuring an immersive program of keynote addresses, expert panels, interactive roundtables, and poster presentations, the event provides a dynamic environment for dialogue and discovery.

A Premium, All-Inclusive Experience

A Premium, All-Inclusive Experience

Every delegate at the Cell & Gene Therapy Nexus 2027 is treated as a VIP. From curated networking sessions to thoughtfully designed experiences, the Nexus fosters meaningful collaboration and personal comfort, creating the ideal environment for advancing dialogue, building partnerships, and driving progress in cell and gene therapy.

Master the Art of Seamless Conversation

Master the Art of Seamless Conversation

Network with top decision-makers and industry leaders in the cell and gene therapy space. Engage in meaningful one-to-one discussions, exchange valuable insights, explore innovative solutions, and build strategic partnerships that drive collaboration and future growth.

Unlock One-to-One Engagements

Unlock One-to-One Engagements

Connect with fellow delegates through dedicated one-to-one meetings designed to foster collaboration in cell and gene therapy. This flexible format enables you to explore strategic partnerships, exchange insights, and maximize every interaction, ensuring meaningful dialogue and impactful connections throughout the event.

Who Should Attend?

Seniority Level
30% 35% 25% 10%
Top Management C-Suite (30%)
Senior Management (VPs, Heads) (35%)
Middle Management (Directors, Managers) (25%)
Others (10%)
Demographics
35% 25% 15% 10% 10% 5%
Western Europe (35%)
Central Europe (25%)
Southern Europe (15%)
Northern & Eastern Europe (10%)
United Kingdom (10%)
Others (5%)
  • Cell & Stem Cell Biology
  • Gene Editing & CRISPR Technologies
  • Viral & Non-Viral Delivery Technologies
  • CGT Product Development
  • CMC, Upstream Manufacturing & Process Development
  • CGTs & Clinical Trial Design & Operations
  • Analytical Development & Quality
  • Translational Research & Clinical Development
  • Therapeutic Area Innovation
  • Digital, Data & Emerging Technologies
  • CAR-T & Immune Cell Engineering
  • Manufacturing & Process Development
  • Data Science & Digital Tools for Advanced Therapies
  • Regulatory Science & Compliance in Advanced Therapies
  • Oncology Cell & Gene Therapy Innovation
  • Rare Disease Therapeutics Development
  • Nucleic Acid Therapeutics (DNA, RNA, mRNA)
  • Synthetic Biology & Advanced Therapeutic Platforms
  • Modeling & Simulation for Therapy Development
  • Patient Access & Commercialization Strategies
  • Safety, Toxicology & Risk Assessment in Gene Therapy

What to expect at the Cell & Gene Therapy Nexus 2027

  • Next-Generation CGT Modalities & Therapeutic Development
  • CGT Manufacturing & AI-Driven Transformation

We are bringing together leading researchers, clinicians, biotech and pharma executives, solution providers, and investment leaders from across the global biopharmaceutical ecosystem. The event covers the full spectrum of the field, from foundational research and clinical translation to manufacturing, commercialization, and patient impact. With manufacturing involving living cells and complex gene delivery systems, the conference emphasizes the specialized facilities, logistics, and expertise required, while showcasing pioneering breakthroughs and strategies that are driving progress from cells to cures.

Join us to connect, collaborate, and contribute to the next wave of breakthroughs in cell and gene therapy, advancing the frontiers of biology and medical science. This is your opportunity to gain valuable insights, practical strategies, and meaningful industry connections.

  • Engage with Industry Leaders & Build Strategic Connections
  • Shape the Conversation
  • High-level plenaries with leading cell & gene therapy experts.
  • Interactive sessions exploring emerging technologies and innovative approaches in advanced therapies.
  • Targeted networking designed to foster collaborations and scientific partnerships
  • Connect with senior therapy leaders and solution providers in an exclusive, invitation-only setting.
  • Take home applicable frameworks and case studies to strengthen therapy development productivity.
  • Keep pace with emerging scientific, technological, and strategic trends shaping cell & gene therapy.

Our Invited Companies

Showcase Your Solutions at the BioPharma Cell & Gene Therapy Nexus Conference

Take advantage of exclusive opportunities to showcase your scientific expertise, present breakthrough research, and highlight innovative cell & gene therapy solutions. Lead high-level discussions with senior researchers, biotech innovators, and pharma decision-makers, positioning your organization at the forefront of advanced therapies and translational science.

At the Nexus, your participation is active, not passive. Engage directly with decision-makers through presentations, panel and roundtable discussions, solution demonstrations, and targeted 1:1 meetings. This is your chance to influence the conversation, showcase your capabilities, and build meaningful partnerships that deliver real impact in the cell & gene therapy ecosystem.

Schedule At a Glance

08:00 am - 09:00 am
Registration
09:00 am - 09:15 am
Welcome & Chairperson Address
09:15 am - 09:45 am
Panel Discussion 1
09:50 am - 10:20 am
Panel Discussion 2
10:25 am - 11:40 am
Mid-Morning Networking Session
11:45 am - 12:05 am
Presentation 1
12:10 pm - 12:30 pm
Presentation 2
12:35 pm - 12:55 pm
Presentation 3
01:00 pm - 02:00 pm
Lunch Break
02:05 pm - 02:35 pm
Panel Discussion 3
02:40 pm - 02:55 pm
Presentation 4
03:00 pm - 03:30 pm
Panel Discussion 4
03:30 pm - 03:35 pm
Session Closing Remarks
03:35 pm - 05:00 pm
Afternoon Networking Session & Drinks Reception
08:00 am - 09:00 am
Registration
09:00 am - 09:15 am
Welcome & Chairperson Address
09:15 am - 09:45 am
Panel Discussion 1
09:50 am - 10:20 am
Panel Discussion 2
10:25 am - 11:40 am
Mid-Morning Networking Session
11:45 am - 12:05 am
Presentation 1
12:10 pm - 12:30 pm
Presentation 2
12:35 pm - 12:55 pm
Presentation 3
01:00 pm - 02:00 pm
Lunch Break
02:05 pm - 02:35 pm
Panel Discussion 3
02:40 pm - 02:55 pm
Presentation 4
03:00 pm - 03:30 pm
Panel Discussion 4
03:30 pm - 03:35 pm
Session Closing Remarks
03:35 pm - 05:00 pm
Afternoon Networking Session

0

+

Seats

0

Hours

0

+

Speakers

0

+

Exhibitors

Testimonials

Venue

Sheraton Brussels Airport Hotel

Name: Sheraton Brussels Airport Hotel

Address: Brussels Airport, 1930 Brussel, Belgium

Frequently Asked Questions

Got Questions? We’ve Got Answers

The event is designed for senior professionals from pharmaceutical and biotech companies, as well as service providers, CDMOs, and technology providers supporting the cell and gene therapy ecosystem.

The audience includes professionals involved in cell and gene therapy research and development, cell and stem cell biology, gene editing, therapeutic development, translational research, clinical development, CMC, manufacturing, analytical development, quality, regulatory, technology, AI, and digital transformation.

The event brings together a carefully curated, senior-level audience to facilitate meaningful conversations between pharmaceutical and biotech decision-makers and relevant service and solution providers. With approximately 80% of attendees representing pharmaceutical and biotech organizations and 20% representing service providers and solution providers, including CDMOs, the event offers a strong buyer-to-seller balance.

Unlike a large-scale, open trade show, the conference is built around handpicked industry professionals and relevant decision-makers, creating a more focused setting for practical discussions, discovering solutions, exchanging insights, building connections, and exploring new business opportunities.

The event offers a range of participation and partnership options to suit different objectives, including Delegate/Networking Passes, Dedicated Presentations, Panel Discussions, Roundtables, Pre-arrange 1:1 Meetings, Exhibition, Marketing Campaigns, Sponsorship Packages, and customized participation opportunities.

Pharmaceutical and biotech companies can participate as delegates or through speaking formats such as dedicated presentations, panels, and roundtables.

Service providers and solution providers can choose from delegate participation, company presentations, panels, roundtables, exhibition, 1:1 meetings, marketing campaigns, sponsorship, and customized partnership options.

You will meet handpicked senior professionals and decision-makers from pharmaceutical and biotech companies, alongside selected service providers and solution providers supporting the industry. The audience is carefully curated to ensure that participants can connect with professionals relevant to their interests, responsibilities, and business objectives.

You can gain actionable insights and practical knowledge while exploring current industry priorities, benchmarking strategies, discovering emerging technologies, and exchanging experiences with peers.

The event also provides opportunities to build valuable professional relationships, identify potential partners, explore relevant solutions, and develop new business connections.

Key areas include next-generation cell and gene therapy modalities, CAR-T and advanced cell therapies, gene editing, in vivo and ex vivo therapies, iPSC-derived therapies, translational research, clinical development, CMC, advanced manufacturing, analytical development, quality and regulatory considerations, scalability, AI, digital transformation, and commercialization.

Sessions focus on practical development challenges, emerging therapeutic approaches, evolving technologies, industry trends, and strategies shaping the future of cell and gene therapy.

Yes. Dedicated 1:1 meetings are available through the meeting platform.

Participants can review profiles, identify relevant professionals, and connect and interact before the event to discuss their interests and arrange meetings in advance. The platform also allows participants to continue interacting after the event, helping maintain relevant connections and conversations beyond the conference.

Yes. You can participate as a delegate and access the conference sessions, curated networking opportunities, and available 1:1 meetings without taking an exhibition or sponsorship package.

This is an ideal option if your primary objective is to learn, network, exchange experiences, meet relevant professionals, and explore potential business relationships.

Yes. Companies can explore speaking opportunities including panel discussions, dedicated presentations, roundtables, and other available formats. These opportunities allow participants to share expertise, present case studies, discuss industry challenges, and contribute to practical conversations with senior professionals.

Yes. Exhibition and sponsorship opportunities are available for service providers and solution providers looking to increase their visibility within the pharmaceutical and biotech community.

These opportunities are designed to provide maximum visibility, relevant lead generation, direct access to decision-makers, and opportunities to showcase solutions and expertise throughout the event.

You can visit the BioPharma Cell & Gene Therapy Nexus website to explore the event and available participation opportunities.

You can also contact our team at enquiry@nexus-conference.com to request the latest prospectus, discuss your objectives, explore the most suitable participation option, or proceed with registration.

CONFERENCE REGISTRATION

Secure your spot today.